DelveInsight has launched a new report on “Postoperative Nausea and Vomiting – Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Postoperative Nausea and Vomiting – Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Postoperative Nausea and Vomiting, historical and forecasted epidemiology as well as the Postoperative Nausea and Vomiting market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Postoperative Nausea and Vomiting Market Report:
Key benefits of the report:
Got queries? Click here to learn more about the Postoperative Nausea and Vomiting Market Landscape.
Postoperative Nausea and Vomiting Overview
Postoperative nausea and vomiting (PONV) is an enormous problem for patients recovering after surgery. About one-third of people experience vomiting, and half of them experience nausea. Nausea, retching, or vomiting usually occurs during the first 24–48 h after surgery in inpatients. Also, PONV is a common side effect following sedation and general anesthesia.
The consequences of PONV can include increased anxiety for future surgical procedures, increased recovery time and hospital stay, and in severe cases, aspiration pneumonia, incisional hernia or suture dehiscence, bleeding esophageal rupture, and metabolic alkalosis. The causes of the PONV are related to the patient and preoperative, intraoperative, and postoperative factors such as pharyngeal stimulation, opioid medication, hypoxia, hypertension, etc.
Postoperative Nausea and Vomiting Market
The dynamics of the Postoperative Nausea and Vomiting market are anticipated to change in the coming years owing to the expected launch of emerging therapies by key companies such as Vivozon, Avenue Therapeutics, Taiwan Liposome Company, and others during the forecasted period 2019-2032.
Postoperative Nausea and Vomiting Pipeline Therapies and Key Companies
Postoperative Nausea and Vomiting Market Drivers
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Postoperative Nausea and Vomiting Patient Share (%) Overview at a Glance
5. Postoperative Nausea and Vomiting Market Overview at a Glance
6. Postoperative Nausea and Vomiting Disease Background and Overview
7. Postoperative Nausea and Vomiting Epidemiology and Patient Population
8. Country-Specific Patient Population of Postoperative Nausea and Vomiting
9. Postoperative Nausea and Vomiting Current Treatment and Medical Practices
10. Unmet Needs
11. Postoperative Nausea and Vomiting Emerging Therapies
12. Postoperative Nausea and Vomiting Market Outlook
13. Country-Wise Postoperative Nausea and Vomiting Market Analysis (2019–2032)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Postoperative Nausea and Vomiting Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Postoperative Nausea and Vomiting Market Outlook 2032.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: +91-9650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/